Advertisement

Topics

AmorChem Company Profile

18:19 EDT 17th October 2018 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

AMORCHEM ANNOUNCES AN INVESTMENT BY FONDACTION IN ITS FUND

AmorChem is pleased to announce the addition of Fondaction to the limited partners of the AmorChem II Fund L.P. The fund initially closed on September 19, 2017, having raised capi...

Inversago brings in $7mm via Series A

Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...

Inversago Pharma Receives $7 Million in Series A Financing

Proceeds will support the development of new generations of cannabinoid-1 (CB1) receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Sy...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

AMORCHEM L.P.

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

AmorChem

More Information about "AmorChem" on BioPortfolio

We have published hundreds of AmorChem news stories on BioPortfolio along with dozens of AmorChem Clinical Trials and PubMed Articles about AmorChem for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AmorChem Companies in our database. You can also find out about relevant AmorChem Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record